Neurology: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE study




Neurology Minute show

Summary: Dr. Amit Bar-Or, professor and chief of MS at Penn, discusses his paper, "Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis". Show references: https://n.neurology.org/content/early/2020/07/29/WNL.0000000000010380